About 3 results found for searched term "Eribulin" (0.13 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10393 | Eribulin mesylate | Microtubule |
| B1939 mesylate; E7389 mesylate; ER-086526 mesylate | ||
| Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used for the research of metastatic breast cancer. | ||
| M22255 | Eribulin | Microtubule |
| Eribulin | ||
| M25118 | Farletuzumab ecteribulin | Drug-Linker Conjugates for ADC |
| MORAb-202 | ||
| Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a drug-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
